What are the contraindications to the Tdap (Tetanus, diphtheria, and pertussis) booster vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Contraindications to Tdap Booster Vaccination

Absolute contraindications to Tdap booster vaccination include a history of severe allergic reaction (anaphylaxis) to a previous dose or any vaccine component, and a history of encephalopathy within 7 days of a previous pertussis-containing vaccine. 1, 2, 3

Absolute Contraindications

  1. Severe allergic reaction (anaphylaxis)

    • Previous anaphylactic reaction to any component of Tdap vaccine
    • Previous anaphylactic reaction to a prior dose of Tdap or other tetanus/diphtheria/pertussis-containing vaccine 2, 3
  2. Neurological contraindications (for pertussis component only)

    • History of encephalopathy (e.g., coma or prolonged seizures) not attributable to another identifiable cause within 7 days after administration of a previous pertussis-containing vaccine 1
    • In these cases, Td (tetanus-diphtheria) should be administered instead of Tdap 1

Precautions (Require Clinical Assessment)

These conditions require careful evaluation of risks and benefits before administering Tdap:

  1. Neurological conditions

    • Progressive neurologic disorder
    • Uncontrolled epilepsy
    • Progressive encephalopathy until the condition has stabilized 1
  2. History of adverse reactions

    • Guillain-Barré syndrome within 6 weeks after a previous tetanus toxoid-containing vaccine 1, 2
    • History of Arthus-type hypersensitivity reaction after a previous tetanus or diphtheria toxoid-containing vaccine (consider deferring vaccination for at least 10 years since last dose) 1
    • Previous severe local reaction (ELS) after DTP/DTaP or Td that was not an Arthus reaction 1
  3. Acute illness

    • Moderate or severe acute illness with or without fever (defer until resolution) 1, 2

Not Contraindications

The following conditions are NOT contraindications to Tdap vaccination:

  • Stable neurologic disorders, including well-controlled seizures
  • History of seizure disorder that has resolved
  • Cerebral palsy
  • Breastfeeding
  • Mild acute illness with or without low-grade fever
  • Current antibiotic therapy
  • Convalescent phase of illness
  • Premature birth (for age-appropriate vaccinations)
  • Recent exposure to an infectious disease
  • History of non-anaphylactic allergies to medications, foods, insects, or other allergens 1, 2

Special Considerations

  1. Latex sensitivity

    • Some Tdap prefilled syringes may contain latex in the tip caps, which could cause allergic reactions in latex-sensitive individuals 2, 3
  2. Timing of vaccination

    • While earlier guidelines suggested waiting 10 years between tetanus-containing vaccines, more recent research indicates that Tdap can be safely administered at intervals of ≥18 months after a previous tetanus-containing vaccine 4, 5
    • Repeated Tdap vaccination has been shown to have acceptable safety compared to Tdap followed by Td vaccination 5
  3. Management when contraindicated

    • For individuals with contraindications to the pertussis component, Td vaccine should be used instead of Tdap 1
    • Persons with a history of anaphylaxis to components in all Tdap and Td vaccines should be referred to an allergist to determine if they have a specific allergy to tetanus toxoid and whether they can safely receive tetanus toxoid vaccination 1

By carefully evaluating these contraindications and precautions, healthcare providers can safely administer Tdap boosters to appropriate candidates while minimizing risks of adverse events.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tetanus Immunization Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.